Clinical Trial

A Long-term Follow-up Study in Patients Who Received BEAM-101

Name: A Long-term Follow-up Study in Patients Who Received BEAM-101 — clinical trial record (NCT07373639)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a Long-term Follow-up (LTFU) study in patients who received BEAM-101 in the parent study (Study BTX-AUT-001). Eligible patients who received BEAM-101 will be asked to participate in this LTFU study prior to completing Study BTX-AUT-001. Patients who enter into this study will be followed for 13 years (a total of 15 years after receiving BEAM-101).

Trial Details

NCT Number	NCT07373639
Lead Sponsor	Beam Therapeutics Inc.
Conditions	Hemoglobinopathy, Sickle Cell Disease
Enrollment	50 participants
Start Date	2025-12-15
Primary Completion	2043-02-12 (estimated)
Study Completion	2043-02-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-28